Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067311 · ClinicalTrials.gov registry record · NA
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03067311 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 38 participants.
The verdict
NCT03067311, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
To test the feasibility of a clinical trial implementing I-CAT, a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. autonomic, endocrine, immune indices of stress reactivity, symptom severity) and distal measures (function, relapse, quality of life) for 40 people with first episode psychosis in the context of a small randomized controlled trial.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL I-CAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-10-03 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03067311
The ClinicalTrials.gov registry entry for NCT03067311 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT03067311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03067311 about?
NCT03067311 is a clinical study titled "Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy". To test the feasibility of a clinical trial implementing I-CAT, a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. autonomic, endocrine, immune indices of stress reactivity, symptom severity...
What is the current status of trial NCT03067311?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-10-03. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03067311?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), I-CAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03067311?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.